Clinical Trial Update: Terazosin And Metabolic Engagement in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on terazosin for metabolic engagement in Parkinson's disease, spanning Phase 1 and Phase 2, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Terazosin (terazosin)

Snippet

Sponsor: Nandakumar Narayanan | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING